Last update 19 Jun 2025

Autologous genetically modified CD34+ cells(Guangdong Yike Gene Science and Technology)

Overview

Basic Info

Drug Type
Cell therapy
Synonyms-
Target-
Action-
Mechanism-
Therapeutic Areas
Congenital DisordersHemic and Lymphatic DiseasesOther Diseases
Active Indication-
Inactive Indication
Beta-Thalassemia
Originator Organization
Guangdong Iridium Gene Technology Co., Ltd.Guangdong Iridium Gene Technology Co., Ltd.
Active Organization-
Inactive Organization
Guangdong Iridium Gene Technology Co., Ltd.Guangdong Iridium Gene Technology Co., Ltd.
License Organization-
Drug Highest PhasePendingPhase 1/2
First Approval Date-
Regulation-

Related

1
Clinical Trials associated with Autologous genetically modified CD34+ cells(Guangdong Yike Gene Science and Technology)
NCT03276455
/ Unknown statusPhase 1/2IIT
Evaluation of Safety and Efficacy of Transplantation of Autologous Hematopoietic Stem Cell Genetically Modified in Beta-Thalassemia Major
100 Clinical Results associated with Autologous genetically modified CD34+ cells(Guangdong Yike Gene Science and Technology)
Login to view more data
100 Translational Medicine associated with Autologous genetically modified CD34+ cells(Guangdong Yike Gene Science and Technology)
Login to view more data
100 Patents (Medical) associated with Autologous genetically modified CD34+ cells(Guangdong Yike Gene Science and Technology)
Login to view more data
100 Deals associated with Autologous genetically modified CD34+ cells(Guangdong Yike Gene Science and Technology)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Beta-ThalassemiaPhase 2
China
Guangdong Iridium Gene Technology Co., Ltd.Guangdong Iridium Gene Technology Co., Ltd.
15 Sep 2017
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free